Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control Study.
Albanese M, Marrone G, Paolino A, Di Lauro M, Di Daniele F, Chiaramonte C, D'Agostini C, Romani A, Cavaliere A, Guerriero C, Magrini A, Mercuri NB, Di Daniele N, Noce A.
Albanese M, et al. Among authors: romani a.
Pharmaceuticals (Basel). 2022 Feb 19;15(2):253. doi: 10.3390/ph15020253.
Pharmaceuticals (Basel). 2022.
PMID: 35215365
Free PMC article.